OxyElite returns with a new panel behind an old name
A famous stimulant brand is back for Europe with a fully disclosed panel. The disclosure is genuinely good; the case published for three of the inclusions is not.
Weight-loss supplements, weighed honestly.
When the brand name is the health claim: the ASA on GuLP-1
A May ruling held that a weight-loss supplement's own name would be read as a health claim the advertiser could not show was authorised — and that an injection-pen comparison table put it in the territory of prescription medicines.
Green tea extract supplements, reviewed with the safety literature attached
A staple of fat-burner formulas, and the one ingredient here where the most important published finding is about harm rather than benefit.
'Clinically studied' is doing heavy lifting on weight-loss labels
Two words that can mean a rigorous trial or almost nothing at all. Here is what the phrase does not commit a brand to.
Glucomannan, reviewed against its own authorised claim
One of the few weight-management ingredients with a specific authorised health claim behind it in Europe — and a set of conditions most products quietly fail to meet.
GLP-1 drugs reshaped the supplement aisle's marketing language
The supplement category did not compete with prescription weight-loss drugs. It borrowed their vocabulary instead — and that borrowing is the thing worth watching on a label.